Date of management change: September 30, 2022
, -based ADARX Appointed Christopher Prentiss as chief financial officer
ADARX is a genetic medicine company focusing on the editing of Messenger RNA Targeting transcripts and oligonucleotide-based therapeutics.
Christopher Prentiss is Chief Financial Officer at MannKind Corporation. Previously, Christopher held various senior HR leadership roles in the industry.
News
Short ProfileName: Christopher Prentiss
Title: chief financial officer
Company: ADARX
Industry: Pharmaceuticals
Current Contact InfoEmail: *********@mannkindcorp.com
Phone:.***.***.*30*
To get full contact details, please sign in or
Other IT executives who recently changed jobs as well: L'Angevain Deb, Wuhrer Christopher, Boston Lynn, Retamal Henry, Seagull Felicia, Martinez Anthony, Miller Abbey, Ireland David, Dunphy Beth, Cerrato Jason, Richardson Maura
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.
